Stockholders' equity - Summary of share-based compensation expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items] | ||||
| Share-based compensation expense | $ 93 | $ (48) | $ 184 | $ 254 |
| Research and development [Member] | ||||
| Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items] | ||||
| Share-based compensation expense | 33 | 30 | 67 | 60 |
| General and administrative [Member] | ||||
| Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items] | ||||
| Share-based compensation expense | $ 60 | $ (78) | $ 117 | $ 194 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|